Showing 1 to 3 of 3 results


High Cost of Shingles Vaccine in France Sparks Debate
France's decision to include the Shingrix vaccine in its vaccination program for those over 65 is debated due to its high cost (€6 billion over five years) despite high efficacy (79% against shingles, 87% against chronic pain) and the fact that those over 65 account for 72% of hospitalizations relat...
High Cost of Shingles Vaccine in France Sparks Debate
France's decision to include the Shingrix vaccine in its vaccination program for those over 65 is debated due to its high cost (€6 billion over five years) despite high efficacy (79% against shingles, 87% against chronic pain) and the fact that those over 65 account for 72% of hospitalizations relat...
Progress
44% Bias Score


England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug
The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.
England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug
The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.
Progress
48% Bias Score

Russian IVF Proposal Limits Attempts for Older Women
The director of a Russian reproductive medicine institute proposed limiting publicly funded IVF attempts to two or three for women over 40 due to sharply declining success rates with age (from 40-45% under 35 to 9.9% over 40) and high miscarriage rates (45% over 40), mirroring international practice...

Russian IVF Proposal Limits Attempts for Older Women
The director of a Russian reproductive medicine institute proposed limiting publicly funded IVF attempts to two or three for women over 40 due to sharply declining success rates with age (from 40-45% under 35 to 9.9% over 40) and high miscarriage rates (45% over 40), mirroring international practice...
Progress
48% Bias Score
Showing 1 to 3 of 3 results